4/A
Changes in Ownership
Protara Therapeutics, Inc. Filed Acc 0001209191-20-010143
Options or other derivatives
- CEO and President acquired 111,250 shares (grant or award)
From the SEC's structured data for this filing
Protara Therapeutics, Inc. Filed Acc 0001209191-20-010143
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…